CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system

Dominique J. Laster,Nisreen S. Akel,James A. Hendrixson,Alicen James,Julie A. Crawford,Qiang Fu,Stuart B. Berryhill,Jeff D. Thostenson,Intawat Nookaew,Charles A. O’Brien,Melda Onal
DOI: https://doi.org/10.1016/j.isci.2023.107428
IF: 5.8
2023-08-01
iScience
Abstract:Cre-mediated recombination is frequently used for cell type-specific loss of function (LOF) studies. A major limitation of this system is recombination in unwanted cell types. CRISPR interference (CRISPRi) has been used effectively for global LOF in mice. However, cell type-specific CRISPRi, independent of recombination-based systems, has not been reported. To test the feasibility of cell type-specific CRISPRi, we produced two novel knock-in mouse models that achieve gene suppression when used together: one expressing dCas9::KRAB under the control of a cell type-specific promoter and the other expressing a single guide RNA from a safe harbor locus. We then compared the phenotypes of mice in which the same gene was targeted by either CRISPRi or the Cre-loxP system, with cell specificity conferred by <i>Dmp1</i> regulatory elements in both cases. We demonstrate that CRISPRi is effective for cell type-specific LOF and that it provides improved cell type-specificity compared to the Cre-loxP system.
multidisciplinary sciences
What problem does this paper attempt to address?